Suchergebnisse - "Curigliano, G"

PubPharm (152)

51

Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

enthalten in: ESMO open | 2021

von Keam, B. | Machiels, J. | Kim, H. | +22

52

Distribution of the workforce involved in cancer care : a systematic review of the literature

enthalten in: ESMO open | 2021

von Trapani, D. | Murthy, S. | Boniol, M. | +6

53

Beyond the lessons learned from the COVID-19 pandemic : opportunities to optimize clinical trial implementation in oncology

enthalten in: ESMO open | 2021

von Castelo-Branco, L. | Awada, A. | Pentheroudakis, G. | +9

54

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Miles, D. | Ciruelos, E. | Schneeweiss, A. | +116

CommentIn: Ann Oncol. 2021 Oct;32(10):1206-1208. - PMID 34403778

55

Customizing local and systemic therapies for women with early breast cancer : the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Burstein, H. | Curigliano, G. | Thürlimann, B. | +68

56

Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis

enthalten in: Cancer treatment reviews | 2021

von Trillo Aliaga, P. | Spada, F. | Peveri, G. | +9

57

Clinical development and current role of margetuximab for the treatment of breast cancer

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2021

von Tarantino, P. | Uliano, J. | Morganti, S. | +3

58

Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Repetto, M. | Conforti, F. | Pirola, S. | +6

59

Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review

enthalten in: Breast cancer research and treatment | 2021

von Trapani, D. | Giugliano, F. | Uliano, J. | +8

60

Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations : rationale and design of the PEVO basket trial

enthalten in: ESMO open | 2021

von de Guillebon, E. | Jimenez, M. | Mazzarella, L. | +31